The month’s deals see a number of collaboration and licensing deals for technology platforms and new molecule discovery
The trends affecting all segments of the wider healthcare ecosystem
What does the patent landscape look like for antibiotics, vaccines and orphan drugs?
A bumper crop of deals with seven transactions of $1bn or more
A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – it's free to add your pharma/healthcare campaigns. Just contact us.
Infections and Infestations
Love your shoes
Thornton & Ross
Central Nervous System
More from the gallery
Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.
What does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?
Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.
In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.
NHS England's siloed budget and its uncertain
Obesity is on the rise in low- and middle-income countries, particularly in urban settings
The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge
Overcoming flaws in leadership development with pharma companies
Key skills and qualities for a career in medical writing
A good match produces the best results
Senior industry figures are taking an ‘ex-directory’ network
Cubist's Patrick Vink on the company's ambitions in anti-infectives
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone
IBM's Amer Fasihi on the rise of Watson
Winning over HCPs… How to Increase Participant Engagement in Healthcare Market Research
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016.
Data is a great way to connect and align global and local objectives – providing the kind of value that gets local markets engaged in core sales materials and speeding
In today’s medical environment there is a two-fold element of risk that affects a medical device company. It is comprised on the one hand by the risk of improper treatment